Industry NewsWho Owns Your Parts on the Water? Why Your Import Model Is a Bigger Risk Than You Think
If you've ever sourced parts overseas, you've probably focused on price, lead time, and quality. What most procurement managers never think to ask is this: who legally owns those parts while they're crossing the Pacific?
That question has real financial consequences — for your balance sheet, your customs liability, and your ability to recover when something goes wrong. The answer depends entirely on which import model you're using. And if you're dealing directly with an overseas factory, the answer is probably "you are" — which means you're carrying more risk than you may realize.
This post explains the difference between traditional importing and a title-taking model, why it matters in today's trade environment, and what mid-sized manufacturers stand to gain by choosing the right sourcing structure.
What "Taking Title" Actually Means
Title is legal ownership. It's not a technicality — it's the difference between being a victim of a transit loss and being a customer with a clean claim. When goods are lost, damaged, or destroyed in transit, the party holding title at that moment absorbs the financial hit.
In international shipments, Incoterms (shipping terms like FOB, CIF, or DDP) govern when risk passes from seller to buyer. But title transfer is a separate legal question, determined by the contract of sale and the bill of lading — not the Incoterm alone. Many buyers don't realize they've accepted ownership of goods that haven't left the factory floor yet.
When a sourcing partner takes title to the goods — meaning they legally purchase them — they become the owner during manufacturing, inspection, and transit. If a shipment is damaged at sea or held at customs, that's their problem to resolve — not yours to absorb while you wait for a cross-border claim to sort itself out. It's a fundamentally different risk allocation.
The Importer of Record: Who's Actually on the Hook with Customs
The Importer of Record (IOR) is the party legally responsible to US Customs and Border Protection at the moment goods enter the United States. Whoever acts as IOR is accountable for tariff classification, duty payment, and regulatory compliance — and faces penalties if any of those are wrong.
In a traditional import arrangement, the US manufacturer is usually the IOR. That means your procurement team is responsible for correctly classifying every part under the Harmonized Tariff Schedule, paying all applicable duties (including any Section 301 tariffs on Chinese goods), and ensuring compliance with every applicable import regulation. For a company without a dedicated trade compliance department, that's a substantial exposure.
When a title-taking contract manufacturer like 889 Global Solutions acts as IOR, your company is insulated from that liability entirely. You're not the importer. You're the customer of a US supplier. CBP issues, duty disputes, and customs enforcement actions are not your problem — they're ours.
What the Traditional Import Model Actually Exposes You To
Let's be specific about what "direct importing" means in practice. You contract with an overseas factory or use a sourcing agent. You receive an invoice and a bill of lading. You become the IOR. And then one of these things happens:
The parts arrive out of tolerance. You now have a quality dispute with a factory in another country, governed by a legal system that is not yours, under a contract that may or may not be enforceable where the factory operates.
The shipment is damaged in transit. Depending on your Incoterm and your insurance coverage, you may have limited or no recourse against anyone.
Your sourcing agent gets paid anyway. Brokers and agents are often contracted separately from the factory — they earn their fee when the transaction occurs, not when the product is good. You can have a legitimate quality dispute with the manufacturer and still owe the agent their commission.
Winning a legal judgment against an overseas manufacturer and actually collecting on it are two entirely different things. International manufacturing attorneys consistently note that many US companies have no meaningful legal recourse after a dispute because their contract wasn't written for the jurisdiction where the factory operates, or because the entity they contracted with was a shell company with no attachable assets.
None of this is hypothetical. These scenarios play out regularly for US manufacturers who assume that a purchase order and a good-faith handshake are sufficient protection in international manufacturing.
The Dispute Resolution Trap
When something goes wrong with an overseas direct import, the practical question is: where do you go to resolve it?
If your contract specifies Chinese courts and Chinese law — as many factory-issued contracts do — you're litigating in a foreign language, in a foreign legal system, potentially against a party with home-court advantage. If your contract specifies US law but the factory has no US assets, winning a judgment still doesn't mean you collect.
When 889 is your supplier, you dispute with a US company, under US law, in a US jurisdiction — because that's who you bought from. We take ownership of the goods. We take responsibility for quality and delivery. And if there's a problem, you're calling our project management team in Columbus, Ohio — not filing a claim through international arbitration.
That's not just more convenient. It's a categorically different risk profile. Your legal exposure is domestic. Your counterparty has US assets and US accountability. And you have a partner — not a factory — who is invested in resolving the problem because we own the relationship.
Why the Tariff Environment Makes This More Important Than Ever
The current trade landscape has made the IOR question more consequential than it's been in a generation. Tariffs on Chinese goods remain elevated, and the regulatory environment continues to shift. Whoever is the Importer of Record holds the tariff liability first — and some of that liability, including antidumping duties, cannot be reimbursed or reassigned by contract. The IOR bears those costs, period.
When 889 acts as IOR, our team actively manages that exposure. We source across a network of vetted facilities in China, India, Vietnam, and Taiwan — which gives us flexibility to shift production when trade conditions change. We build tariff considerations into our pricing structure so clients get a predictable landed cost rather than a surprise on their customs entry summary.
For manufacturers trying to plan procurement budgets in an unpredictable trade environment, that kind of cost visibility matters. You're not guessing what your duty exposure will be next quarter — you're buying from a US supplier at a fixed price.
How 889's Model Works in Practice
889 Global Solutions has operated as a title-taking contract manufacturer and sourcing partner for 26 years. Here's what that means operationally:
We purchase the goods. We take legal ownership from the moment of production, through inspection, through transit, through US customs entry. You don't become the owner until we deliver to you — domestically, on terms you understand.
We act as the FDA-registered initial importer for medical device clients. For companies sourcing components for medical applications, that registration matters. Our partner facilities hold ISO 13485 certification, meaning production quality meets the standard for medical device manufacturing — and our clients don't need to maintain their own foreign supplier qualification programs for the components we source.
Our bilingual project management team has staff on the ground in Asia. They visit your factory before, during, and after production. They catch quality issues before goods ship — not after they arrive in your warehouse.
We serve as your outsourced sourcing department — handling supplier qualification, production scheduling, QC inspection, logistics, and domestic warehousing, all under one point of contact. Our partner facilities are certified to ISO 9001 for general manufacturing quality and ISO 13485 for medical device applications. Our clients have documented cost savings of 20–50% compared to domestic sourcing, without the overhead of managing international supplier relationships themselves.
We're also MBE/WBE certified, which matters for manufacturers with supplier diversity requirements in their procurement programs.
The Right Model for the Right Company
A traditional import model isn't inherently wrong. Large companies with dedicated import compliance teams, experienced international legal counsel, and deep factory relationships can manage direct overseas procurement effectively. For them, the overhead is justified by the volume.
But for most mid-sized US manufacturers — companies that need the cost advantages of Asian manufacturing without the infrastructure to manage international legal exposure, customs compliance, and cross-border dispute resolution — the title-taking model isn't just more convenient. It's structurally safer.
You're not just buying cheaper parts. You're buying a supply chain relationship where accountability is built in, because your supplier legally owns what they're selling you.
Key Takeaways
Ready to talk about your sourcing situation? Contact 889 Global Solutions now!
This post is for general informational purposes only and does not constitute legal or trade compliance advice. For guidance specific to your business, consult a licensed professional.